Improve your operational efficiency with fast access to the research you need – now. Respond efficiently to the competing pressures faced by the ‘buy’ and ‘sell’ side.
On the sell side
Challenged to rationalise the cost of research whilst maintaining competitive coverage, the sell side is now facing a wave of consolidation and a renewed focus on research quality.
Benefit from the combined intellectual might of sector specialist teams and experienced analyst team, all armed with the right tools and techniques to produce high quality and differentiated research for you.
Widen your coverage universe without facing an equivalent cost increase, thanks to our scalable and powerful technology-enabled solution.
On the buy side
Regulation is driving the unbundling of research and greater scrutiny of buy side’s research leading to budgetary restraints on the procurement. Firms are looking to maximise spend and improve efficiencies alongside effectiveness of in-house research teams.
Our digital delivery platform gives you a cost-effective tool to augment your in-house research capacity. Get instant access to high quality standardised reports that delivers on your fundamental research needs – from independent financial and valuation models to in-depth investment commentary to real-time portfolio performance tracking and risk analytics. Available all in one place – reusable, scalable.
Benefits for your business
Cost effective research
Uncompromised quality delivered cost effectively to meet your needs.
Fast instance access
Get instant access to high quality standardised reports that serves your fundamental research needs.
Capitalise on our expertise
Tap into our highly skilled modellers, analytics experts and quantitative analysts who will add value to you and your team, combined with state-of-the-art technology.
Case study : Increasing research coverage
A Paris based client requested our support in order to ramp up research coverage at the time of their flotation. The engagement targeted an operating model that offered scalable research with minimal lead-time.Find out more